Japanese information and communication technology giant Fujitsu has jointly developed an ultra-high throughput drug discovery system it says can not only dramatically reduce R&D lead times but can als
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in
Boston – Cloud Pharmaceuticals Inc. Chief Operating Officer Don Van Dyke spoke with Scrip at BioPharm America 2016 about how the company uses cloud computing to accelerate the discovery and des